NCT01693068
Clinical Trial Detail
Contact
Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT01693068 |
| Title | Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | Yes |
| Sponsors | EMD Serono |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | SWE | NZL | NLD | ITA | ISR | GBR | FRA | ESP | DEU | CHE | BEL | AUS |
CKB BOOST